Oncology
MPLN's hematology oncology and solid tumor menus are designed to address every stage of patient management to support diagnosis, risk stratification, treatment selection and clinical course monitoring. Using complementary technologies and StrataFLEX™ , MPLN delivers comprehensive integrated analyses.A leader in molecular and cellular diagnostics, MPLN is often among the first laboratories in the country to offer the latest new tests and advancements in technologies.
Hematopathology
FLT3 mutation and acute leukemia »
JAK2 and myeloproliferative disorder »
Minimal residual disease testing »
Solid Tumor
Bladder cancer and UroVysion »


